UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
MEDICAL DEVICES, DIAGNOSTICS & EQUIPMENT

Haag-Streit

Ophthalmic diagnostic and surgical equipment manufacturer

Haag-Streit logo

Haag-Streit

Ophthalmic diagnostic and surgical equipment manufacturer

Visit Website

About Haag-Streit

For more than 160 years, Haag-Streit has been the reference standard for ophthalmic diagnostics and surgical equipment, with its slit lamp remaining the instrument against which all others in the field are measured. Headquartered in Koeniz, near Bern, Switzerland, the company operates as part of the Metall Zug Group and supplies eye care professionals and hospitals across the globe.

Diagnostic & Surgical Instrumentation

The company's portfolio spans the full clinical workflow in ophthalmology. Its slit lamps are used in optometric and ophthalmic practices worldwide, while its perimetry systems, biometers, and surgical microscopes are fixtures in hospital eye units. The Haag-Streit BQ 900 slit lamp in particular has become a universally recognised diagnostic benchmark. Alongside diagnostics, the group produces and distributes surgical microscopes and operating room equipment suited to cataract, retinal, and anterior segment procedures.

Global Distribution & Group Structure

Haag-Streit operates through several specialist subsidiaries, including Haag-Streit Diagnostics, Haag-Streit Surgical, and Haag-Streit UK, giving the group both direct market presence and dedicated service infrastructure in key territories. Products reach clinicians through a network of distributors spanning Europe, North America, Asia-Pacific, and beyond. The Swiss manufacturing base underpins the precision engineering reputation the brand has built over generations.

Further information is available at haag-streit.com.

Areas of Expertise

Eye CareOphthalmology

Services & Capabilities

Eye CareOphthalmology
Similar Companies

More in Medical Devices, Diagnostics & Equipment

O

Oertli Instrumente

Oertli Instrumente has been engineering precision ophthalmic surgical systems from Switzerland for more than seven decades, establishing itself as a specialist in the technology that surgeons depend on for cataract, vitreoretinal, and anterior segment procedures.Based in Berneck, the company designs and manufactures phacoemulsification and vitreoretinal platforms used in operating theatres worldwide. Its product portfolio centres on surgical consoles, handpieces, and accessories built to the exacting standards that microsurgery demands. The focus on ophthalmology as a single discipline allows Oertli to develop deep technical expertise in fluidics, ultrasound delivery, and integrated surgical control, rather than spreading development resource across multiple therapeutic categories.Oertli's systems are distributed across Europe, Asia, and the Americas, with a network of clinical and technical support that reflects the company's emphasis on long-term relationships with surgical teams. The privately held structure keeps decision-making close to the engineering and clinical teams, a model the company has sustained through successive generations of platform development.The OS 4 surgical system is among its most recognised platforms, integrating cataract and vitreoretinal functionality within a single console. This kind of consolidation is increasingly valued in ophthalmic theatres where space, workflow efficiency, and consistent performance across procedure types are operational priorities.Further information is available at oertli-instruments.com.

View profile
V

Viz.ai

Viz.ai pioneered the use of artificial intelligence to accelerate time-to-treatment for life-threatening conditions, connecting care teams in real time when minutes determine outcomes. Founded in 2016 and headquartered in San Francisco, California, the company built its platform around the insight that detecting a large vessel occlusion stroke on a CT scan and alerting the right specialist within seconds, rather than hours, can preserve neurological function at scale.AI-Powered Care Coordination PlatformThe Viz platform analyses medical imaging as it comes off the scanner, applies FDA-cleared AI algorithms to detect abnormalities, and simultaneously routes automated alerts to on-call specialists via a dedicated care-team communication app. What began in stroke expanded into a broad portfolio covering pulmonary embolism, aortic disease, cardiac conditions, and oncology pathways. The company markets this as a care coordination network rather than a standalone diagnostic tool, emphasising workflow integration alongside detection.Scale & Hospital NetworkViz.ai operates across hundreds of hospitals in the United States and has expanded internationally. Its network model means that as more sites connect, the routing intelligence spans entire health systems and transfer networks, enabling spoke hospitals to reach comprehensive stroke centres rapidly. The company raised substantial venture funding before moving towards broader commercial expansion, and its devices have received multiple FDA 510(k) clearances across different clinical indications.Customers include academic medical centres, integrated delivery networks, and community hospitals seeking to standardise time-sensitive clinical pathways without restructuring radiology or specialist staffing. The platform sits within existing PACS and EHR workflows, reducing the implementation burden.Further information is available at viz.ai.

View profile
A

Aerogen

With technology deployed in more than 80 countries and used to treat over 30 million patients, Aerogen has established itself as the global leader in acute care aerosol drug delivery. Founded in Galway, Ireland, the company built its reputation on a single, well-defined mission: ensuring that critically ill patients receive inhaled medication reliably, precisely, and without disrupting the ventilation or oxygenation they depend on.Vibrating Mesh Nebuliser PlatformThe company's core technology is the vibrating mesh nebuliser, a platform protected by more than 300 international patents and referenced in over 300 clinical publications. At the heart of the system is a mesh containing thousands of precision-formed apertures that act as a micropump, converting liquid medication into a fine, low-velocity aerosol optimised for deep lung deposition. The Aerogen Solo, the flagship single-patient-use device, is integrated into ventilator platforms from GE Healthcare, Draeger, Philips, Covidien, and virtually every major manufacturer of critical care ventilators, making it the de facto standard across intensive care units worldwide.One System Across the Respiratory JourneyA defining feature of the Aerogen portfolio is its continuity of care design. A single Aerogen Solo device supports patients across every stage of their hospital respiratory journey, from invasive mechanical ventilation in the ICU through non-invasive ventilation, high-flow nasal cannula therapy, and self-ventilating recovery, without the need to change hardware or recalibrate dosing. The Aerogen Ultra extends this flexibility by providing a handheld option for ambulatory or step-down settings. The continuous nebulisation tube set rounds out the range, enabling extended, precisely controlled drug administration where sustained dosing is clinically indicated.Aerogen operates internationally, with facilities in Galway, Ireland, and commercial presence across North America, Europe, and Asia-Pacific. The company supports a broad formulary of inhaled agents, including bronchodilators, corticosteroids, mucolytics, and antimicrobials, reflecting the breadth of pharmacological need in acute respiratory care.Further information is available at aerogen.com.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy